Alaghemandan H, Ghaffari Darab M, Khorasani E, Namazi E, Maniyan MH, Barati M. Personality traits and their relationship to demographic features in addicts referring to a drug rehabilitation center in the city of Isfahan, Iran. Iran J Public Health 2015; 44(4): 551-60.
Naserbakht M, Djalalinia S, Tayefi B, Gholami M, Eftekhar Ardabili M, Shariat SV, et al. National and sub-national prevalence, trend, and burden of mental disorders and substance abuse in Iran: 1. Arch Iran Med 2014; 17(3): 182-8.
Karajibani M, Montazerifar F, Shakiba M. Evaluation of nutritional status in drug users referred to the center of drug dependency treatment in Zahedan. High Risk Behav Addict 2012; 1(1): 18-21.
McLellan AT, McKay JR, Forman R, Cacciola J, Kemp J. Reconsidering the evaluation of addiction treatment: From retrospective follow-up to concurrent recovery monitoring. Addiction 2005; 100(4): 447-58.
Blume AW. Treating drug problems. New York, NY: John Wiley & Sons; 2005.
Goldstein RZ, Volkow ND. Dysfunction of the prefrontal cortex in addiction: Neuroimaging findings and clinical implications. Nat Rev Neurosci 2011; 12(11): 652-69.
Meil W, LaPorte D, Stewart P. Substance dependence as a neurological disorder Ken-Shiung Chen Dr, advanced topics in neurological disorders [Online]. [cited 2012]; Available from: URL: http://cdn.intechopen.com/pdfs/32484/InTech Substance_dependence_as_a_neurological_disorder.pdf
Heinz AJ, Bui L, Thomas KM, Blonigen DM. Distinct facets of impulsivity exhibit differential associations with substance use disorder treatment processes: A cross-sectional and prospective investigation among military veterans. J Subst Abuse Treat 2015; 55: 21-8.
Coskunpinar A, Dir AL, Cyders MA. Multidimensionality in impulsivity and alcohol use: A meta-analysis using the UPPS model of impulsivity. Alcohol Clin Exp Res 2013; 37(9): 1441-50.
Dick DM, Smith G, Olausson P, Mitchell SH, Leeman RF, O'Malley SS, et al. Understanding the construct of impulsivity and its relationship to alcohol use disorders. Addict Biol 2010; 15(2): 217-26.
Loree AM, Lundahl LH, Ledgerwood DM. Impulsivity as a predictor of treatment outcome in substance use disorders: Review and synthesis. Drug Alcohol Rev 2015; 34(2): 119-34.
Stevens L, Verdejo-Garcia A, Goudriaan AE, Roeyers H, Dom G, Vanderplasschen W. Impulsivity as a vulnerability factor for poor addiction treatment outcomes: A review of neurocognitive findings among individuals with substance use disorders. J Subst Abuse Treat 2014; 47(1): 58-72.
Streeter CC, Terhune DB, Whitfield TH, Gruber S, Sarid-Segal O, Silveri MM, et al. Performance on the Stroop predicts treatment compliance in cocaine-dependent individuals. Neuropsychopharmacology 2008; 33(4): 827-36.
King KM, Fleming CB, Monahan KC, Catalano RF. Changes in self-control problems and attention problems during middle school predict alcohol, tobacco, and marijuana use during high school. Psychol Addict Behav 2011; 25(1): 69-79.
Blonigen DM, Timko C, Moos BS, Moos RH. Treatment, alcoholics anonymous, and 16-year changes in impulsivity and legal problems among men and women with alcohol use disorders. J Stud Alcohol Drugs 2009; 70(5): 714-25.
Blonigen DM, Timko C, Moos RH. Alcoholics anonymous and reduced impulsivity: A novel mechanism of change. Subst Abus 2013; 34(1): 4-12.
Marlatt GA, Donovan DM. Relapse prevention: Maintenance strategies in the treatment of addictive behaviors. 2nd ed. New York, NY: Guilford Press; 2005.
Witkiewitz K, Alan MG, Denise W. Mindfulness-based relapse prevention for alcohol and substance use disorders. J Cogn Psychother 2005; 19(3): 211-28.
Witkiewitz K, Bowen S, Douglas H, Hsu SH. Mindfulness-based relapse prevention for substance craving. Addict Behav 2013; 38(2): 1563-71.
Hsu SH, Collins SE, Marlatt GA. Examining psychometric properties of distress tolerance and its moderation of mindfulness-based relapse prevention effects on alcohol and other drug use outcomes. Addict Behav 2013; 38(3): 1852-8.
Imani S, Atef Vahid MK, Gharraee B, Habibi M, Bowen S, Noroozi A. Comparing mindfulness-based group therapy with treatment as usual for opioid dependents: A pilot randomized clinical trial study protocol. Iran J Psychiatry Behav Sci 2015; 9(1): e216.
Tang YY, Tang R, Posner MI. Mindfulness meditation improves emotion regulation and reduces drug abuse. Drug Alcohol Depend 2016; 163(Suppl 1): S13-S18.
Breslin FC, Zack M, McMain S. An Information-Processing Analysis of Mindfulness: Implications for Relapse Prevention in the Treatment of Substance Abuse. Clin Psychol 2002; 9(3): 275-99.
Tiffany ST. A cognitive model of drug urges and drug-use behavior: Role of automatic and nonautomatic processes. Psychol Rev 1990; 97(2): 147-68.
Axelrod SR, Perepletchikova F, Holtzman K, Sinha R. Emotion regulation and substance use frequency in women with substance dependence and borderline personality disorder receiving dialectical behavior therapy. Am J Drug Alcohol Abuse 2011; 37(1): 37-42.
Brewer JA, Elwafi HM, Davis JH. Craving to quit: Psychological models and neurobiological mechanisms of mindfulness training as treatment for addictions. Psychol Addict Behav 2013; 27(2): 366-79.
Barratt ES, Stanford MS, Kent TA, Felthous A. Neuropsychological and cognitive psychophysiological substrates of impulsive aggression. Biol Psychiatry 1997; 41(10): 1045-61.
Naderi F, Haghshenas F. The relationship between impulsivity, loneliness and the mobile phone usage rate in male and female students of Ahvaz Islamic Azad University. Journal of Social Psychology 2009; 4(12): 111-21. [In Persian].
Shorey RC, Elmquist J, Wolford-Clevenger C, Gawrysiak MJ, Anderson S, Stuart GL. The relationship between dispositional mindfulness, borderline personality features, and suicidal ideation in a sample of women in residential substance use treatment. Psychiatry Res 2016; 238: 122-8.
Holzel BK, Lazar SW, Gard T, Schuman-Olivier Z, Vago DR, Ott U. How does mindfulness meditation work? Proposing mechanisms of action from a conceptual and neural perspective. Perspect Psychol Sci 2011; 6(6): 537-59.
Liu YP, Huang TS, Tung CS, Lin CC. Effects of atomoxetine on attention and impulsivity in the five-choice serial reaction time task in rats with lesions of dorsal noradrenergic ascending bundle. Prog Neuropsychopharmacol Biol Psychiatry 2015; 56: 81-90.
Potenza MN, Sofuoglu M, Carroll KM, Rounsaville BJ. Neuroscience of behavioral and pharmacological treatments for addictions. Neuron 2011; 69(4): 695-712.
Bowen S, Witkiewitz K, Clifasefi SL, Grow J, Chawla N, Hsu SH, et al. Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: A randomized clinical trial. JAMA Psychiatry 2014; 71(5): 547-56.
Bowen S, Chawla N, Collins SE, Witkiewitz K, Hsu S, Grow J, et al. Mindfulness-based relapse prevention for substance use disorders: A pilot efficacy trial. Subst Abus 2009; 30(4): 295-305.
Heeren A, Philippot P. Changes in Ruminative thinking mediate the clinical benefits of mindfulness: Preliminary findings. Mindfulness 2011; 2(1): 8-13.
Shapiro SL, Carlson LE, Astin JA, Freedman B. Mechanisms of mindfulness. J Clin Psychol 2006; 62(3): 373-86.
Grabovac AD, Lau MA, Willett BR. Mechanisms of mindfulness: A buddhist psychological model. Mindfulness 2011; 2(3): 154-66.
Kalivas PW, Volkow ND. The neural basis of addiction: A pathology of motivation and choice. Am J Psychiatry 2005; 162(8): 1403-13.